AstraZeneca to Release Trial Data for Covid-19 Vaccine by Year End
Currently, AstraZeneca vaccine trials are in the late-stages, involving about 23,000 participants. The participants span across the UK, U.S., South Africa, and Brazil.British-Swedish pharmaceutical company AstraZeneca Plc (LON: AZN) hopes to release its vaccine data by the end of the year. The drugmaker announced the development as it reports a
Read More